Product Program year 2024 Source: CMS Open Payments

Ivig

Biological Immunology

Open in the dashboard

General payments

$29,114

23 payments

Research payments

$0

0 payments

Through program year 2024, $29,114 in general payments and $0 in research payments were reported against Ivig (Immunology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2024 General $29,114 23

Breakdown

Who paid General payments · program year 2024
  1. Octapharma USA, Inc. $29,114 23 payments
Top recipients General payments · program year 2024
  1. Manish Butte Pediatric Allergy/Immunology · Los Angeles, CA $15,883 55% · 5 payments
  2. Ajai Chari Hematology & Oncology · New York, NY $13,231 45% · 18 payments

Each share is of general payments naming this product in 2024.

Specialties paid General payments · program year 2024
  1. Pediatric Allergy/Immunology Pediatrics $15,883 55% · 1 practitioner
  2. Hematology & Oncology Internal Medicine $13,231 45% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2024
  1. California $15,883 55% · 1 recipient
  2. New York $13,231 45% · 1 recipient

Each share is of general payments naming this product in 2024 where a state was reported.

23 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record